QFLD · SVC-002
Controlled substance records kept current, accurate, and ready for inspection
Specialized financial tracking of controlled substance inventories — acquisition costs recorded, perpetual records maintained, and discrepancies documented before they become a compliance problem.
THE PROMISE · QFLD-P01
Controlled substance inventory accounting that satisfies regulators and gives you clarity
When controlled substance inventory records are maintained properly month to month — acquisition costs recorded at time of receipt, perpetual counts reconciled against physical inventory, discrepancies documented as they arise — an inspection becomes a routine event rather than an urgent scramble.
This service produces that kind of record. It's built for pharmacies that dispense controlled substances and need financial documentation structured to meet regulatory requirements, maintained as a matter of course rather than assembled retroactively.
What you can expect
-
Perpetual inventory records maintained monthly
Acquisition costs and dispensing activity tracked on a running basis, with count reconciliation performed each period against your physical inventory figures.
-
Discrepancies documented as they appear
Any variance between recorded and physical counts is noted, described, and included in the monthly record — not left to accumulate into a larger unexplained gap.
-
Records structured for regulatory inspection
Documentation organized to meet the requirements of regulatory authorities — accessible and clearly structured when an inspection occurs, with no last-minute assembly required.
THE SITUATION · QFLD-P02
Controlled substance record-keeping carries a particular kind of pressure
The financial side of controlled substance inventory tends to fall into a gap between operational logs and general accounting. Dispensing software tracks what was dispensed. The general ledger tracks what was purchased. But the continuous financial reconciliation — acquisition cost against perpetual count, physical inventory against recorded balance — often doesn't get the dedicated attention it requires.
That gap is where discrepancies accumulate and where regulatory risk sits. It's also where a dedicated monthly process makes a meaningful difference — not as a one-time clean-up, but as an ongoing accounting discipline.
Where problems tend to arise
-
—
Acquisition costs recorded inconsistently across suppliers and purchase cycles
-
—
Physical count variances left undocumented until a formal inspection requires explanation
-
—
Perpetual records that don't reconcile against the physical inventory without significant reconstruction
-
—
Documentation maintained in formats not aligned with what regulatory authorities expect to see
THE APPROACH · QFLD-P03
A dedicated accounting layer for controlled substance inventories
This service addresses the financial record-keeping dimension of controlled substance inventory — distinct from operational dispensing logs, and structured to complement your broader pharmacy accounting.
Acquisition cost recording
Every controlled substance purchase is recorded at acquisition cost when received, organized by substance, supplier, and schedule. Consistent cost basis across all purchasing activity, regardless of how many suppliers or purchase cycles are involved.
Perpetual inventory maintenance
A running financial record of inventory on hand is maintained month to month, updated as receipts and dispensing activity are recorded. This provides a continuous balance against which physical counts can be checked at any point.
Periodic count reconciliation
Physical inventory counts are reconciled against perpetual records each period. Any variances are identified, noted with context where available, and carried forward clearly in the documentation rather than adjusted away without explanation.
THE ENGAGEMENT · QFLD-P04
What working together looks like
This service is designed as a specialized add-on, typically used alongside broader pharmacy accounting. The setup process takes into account whatever records and systems are already in place.
Review of current records
We start by reviewing your existing controlled substance records — dispensing logs, purchase history, and any current inventory documentation — to understand what's in place and what the reconciliation process needs to address.
Record structure setup
The accounting framework for tracking acquisition costs and perpetual inventory is set up around your specific substances, schedules, and supplier structure. This is done once and then maintained on a monthly basis going forward.
Monthly reconciliation
Each month, acquisition data is recorded, the perpetual inventory is updated, and physical count reconciliation is completed. A summary of the period's activity and any noted discrepancies is provided in writing.
Maintained documentation
Records are kept organized and accessible throughout the year. When an inspection is scheduled or announced, the documentation is already in order — no preparation period required on your end.
THE INVESTMENT · QFLD-P05
$300 USD per month
This covers the monthly accounting work for controlled substance inventories — acquisition cost recording, perpetual inventory maintenance, periodic count reconciliation, and discrepancy documentation structured for regulatory review.
The service is priced as a specialized add-on, typically used alongside the Pharmacy & Dispensary Accounting service. It can also be used independently if your existing accounting is already handled elsewhere and this specific layer is what's missing.
The initial conversation includes a review of your current records so the scope is clear and the monthly investment reflects the actual work involved before any commitment is made.
What's included
-
Acquisition cost recording at time of receipt, by substance and supplier
-
Perpetual inventory maintenance updated each period
-
Periodic count reconciliation against physical inventory figures
-
Documentation of any discrepancies with contextual notes where available
-
Records organized in a format suitable for regulatory authority inspection
-
Monthly summary of period activity and any noted variances provided in writing
-
Compatible with existing pharmacy accounting — integrates without duplication
THE FRAMEWORK · QFLD-P06
How the accounting is structured and what it produces
The methodology follows the financial record-keeping cycle for controlled substance inventory — from receipt through to period reconciliation and documentation.
Receipt layer
Acquisition recording
Each purchase is recorded as received — substance, schedule, quantity, supplier, and cost. This forms the cost basis for inventory valuation and the opening entry in the perpetual record for each lot.
Recorded at receipt · Per-substance detail
Inventory layer
Perpetual maintenance
The running balance for each substance is updated as dispensing activity is recorded. The perpetual record is the reference point for reconciliation — it represents what the count should be before physical inventory is taken.
Updated monthly · Continuous balance
Reconciliation layer
Count reconciliation and documentation
Physical counts provided by your pharmacy are compared against the perpetual record. Variances are documented in the period record with as much context as is available. The output is a completed reconciliation suitable for inspection review.
Completed each period · Inspection-ready
OUR COMMITMENT · QFLD-P07
Consistent work each month, not records assembled when pressure arrives
The value of this service comes from regularity. A single month's reconciliation is useful. A year of consistently maintained, well-documented records is what makes regulatory interactions manageable and removes the chronic background concern that the books might not hold up under scrutiny.
The initial consultation carries no obligation. We ask a few specific questions about your substances, volumes, and current documentation before outlining what the engagement involves — so you have a clear picture of the work before anything starts.
What you can count on
-
→
Initial consultation with no cost or commitment required
-
→
Written scope and service terms before the engagement begins
-
→
Monthly delivery on a consistent schedule — not delayed or batched
-
→
Documentation accessible throughout the year, not only at period end
-
→
Direct communication if a discrepancy raises a question that warrants your attention
NEXT STEPS · QFLD-P08
How to get started
The process is straightforward. A short message is all that's needed to begin — no lengthy intake forms, no commitment at this stage.
Send a brief message
Use the contact form on the main page. A few details about your pharmacy — substances dispensed, whether you currently have an accounting provider, and what your current documentation looks like — is enough to start a useful conversation.
Initial records review
After the initial exchange, we'll ask for a look at your current controlled substance records — purchase logs, dispensing data, any existing inventory documentation. This shapes the setup process and confirms the scope.
Clear written outline
Before anything begins, you receive a written description of the engagement — what's covered, what the monthly process involves, and what the timeline for setup looks like. No surprises once the work starts.
GET STARTED · QFLD-P09
Ready to put controlled substance records on a consistent footing?
Send a brief message using the contact form. A short description of your pharmacy and current documentation setup is all we need to begin a useful conversation.
Send a messageOTHER SERVICES · QFLD-P10
Explore related services
This service is often used alongside the broader pharmacy accounting service. The third-party payer reconciliation service is available separately for pharmacies with specific needs in that area.
Pharmacy & Dispensary Accounting
Complete monthly accounting for independent pharmacies and dispensaries — prescription revenue, reimbursement reconciliation, margin analysis by category, and regulatory documentation. The broader service that this add-on complements.
Third-Party Payer Reconciliation
Monthly reconciliation of payments from insurers, government programs, and other third-party payers against submitted claims. Clear aging summary by payer, with underpayments and denial patterns surfaced each month.